David Delaney - 09 Aug 2022 Form 3 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Member of 10% owner group
Signature
/s/ David Delaney
Issuer symbol
KTTA
Transactions as of
09 Aug 2022
Net transactions value
$0
Form type
3
Filing time
16 Aug 2022, 17:56:00 UTC
Next filing
19 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KTTA Common Stock 226,521 09 Aug 2022 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 191,321 shares are held by Concord IP2, Ltd., of which David Delaney serves as sole director and President, and 35,200 shares are held by Elderhill Corporation, of which David Delaney serves as sole director and President.